Average bioequivalence of single 500 mg doses of two oral formulations of levofloxacin: a randomized, open-label, two-period crossover study in healthy adult Brazilian volunteers . Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 51, n. 1, p. 203–211, 2015. DOI: 10.1590/S1984-82502015000100020. Disponível em: https://revistas.usp.br/bjps/article/view/100513.. Acesso em: 24 jul. 2024.